New patent expiration for Boehringer Ingelheim drug APTIVUS

Annual Drug Patent Expirations for APTIVUS Aptivus is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. There are three patents… The post New patent expiration for Boehringer Ingelheim drug APTIVUS appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: